Antibiotic-associated Vulvovaginal Candidiasis

Jinping Xu1, Jack D. Sobel

  • 1101 East Alexandrine, 2nd floor, Detroit, MI 48201, USA. jxu@med.wayne.edu

Insights

Antibiotic overuse may increase vulvovaginal candidiasis (VVC) risk. This review examines the limited evidence and conflicting data on antibiotic-associated VVC, exploring its incidence and mechanisms.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Women's Health

Background:

  • Vulvovaginal candidiasis (VVC) is a common cause of vaginitis with increasing incidence.
  • Antibiotic overuse is a suspected contributor to rising VVC rates.
  • Existing evidence linking antibiotics to VVC is limited and conflicting.

Purpose of the Study:

  • To review the literature on antibiotic-associated VVC.
  • To examine the incidence and potential mechanisms of VVC after antibiotic use.
  • To discuss clinical and research implications.

Main Methods:

  • Systematic literature review of studies on antibiotic-associated VVC.
  • Analysis of incidence data and proposed pathogenic mechanisms.
  • Evaluation of clinical and research findings.

Main Results:

  • Evidence directly linking antibiotic use to VVC is scarce and methodologically limited.
  • Conflicting data exists regarding the precise risk of developing VVC post-antibiotic treatment.
  • Potential mechanisms involve disruption of the vaginal microbiome.

Conclusions:

  • Further rigorous research is needed to confirm the association between antibiotics and VVC.
  • Understanding the mechanisms is crucial for clinical management and prevention strategies.
  • The review highlights the need for cautious antibiotic prescribing and further investigation.

Related Concept Videos

Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...